Skip to main content
ICCM
NASDAQ Industrial Applications And Services

IceCure Medical Regains Nasdaq Compliance Following Reverse Stock Split

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$8.25
Mkt Cap
$26.102M
52W Low
$2.12
52W High
$42
52W Position info
289% above low
Off High info
80% below high
Rel. Volume info
4.3× avg
Market data snapshot near publication time

ICCM has more than doubled off its 52-week low of $2.12 on elevated volume (4.3× avg).

Summary

IceCure Medical announced it has regained compliance with the Nasdaq minimum bid price requirement, effectively resolving the delisting threat following its recent reverse stock split.


Key Events · Corporate Governance and Compliance · ICCM

  • Regains Nasdaq Compliance

    IceCure Medical received notice from Nasdaq on June 18, 2026, confirming it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)).

  • Follows Reverse Stock Split

    Compliance was achieved after the company's ordinary shares maintained a closing bid price of $1.00 or greater for 10 consecutive business days, from June 4 to June 17, 2026, following a 1-for-30 reverse stock split effective June 4, 2026.

  • Delisting Threat Removed

    The successful regaining of compliance means the bid price deficiency matter is now closed, removing the immediate risk of delisting from Nasdaq.


Analysis · ICCM · Industrial Applications And Services

This filing confirms that IceCure Medical has successfully regained compliance with Nasdaq's minimum bid price requirement. This is a critical positive development, as it removes the immediate threat of delisting, which was a significant overhang for the company and its investors. The compliance was achieved after the previously announced 1-for-30 reverse stock split, effective June 4, 2026, boosted the share price above the $1.00 threshold for the required 10 consecutive business days.

How filings like this one have moved

In the 30 days to Oct 22, 2026, 36.9% of the 1029 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ICCM was trading at $8.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $26.1M. The 52-week trading range was $2.12 to $42.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ICCM - Latest Insights

ICCM
Oct 05, 2026, 6:30 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $1.08 info
Change: -$0.520 (-33%) info
Market Cap: $3.701M info
ICCM
Sep 10, 2026, 8:59 AM EDT
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $2.08
Real-time Price: $1.08 info
Change: -$1.00 (-48%) info
Market Cap: $3.701M info
ICCM
Sep 10, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $2.12
Real-time Price: $1.08 info
Change: -$1.04 (-49%) info
Market Cap: $3.701M info
ICCM
Aug 24, 2026, 7:50 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $2.48
Real-time Price: $1.08 info
Change: -$1.40 (-56%) info
Market Cap: $3.701M info
ICCM
Aug 12, 2026, 8:45 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $3.20
Real-time Price: $1.08 info
Change: -$2.12 (-66%) info
Market Cap: $3.701M info